Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Painful Bladder Syndrome, Interstitial Cystitis, Bladder Pain Syndrome

In brief

A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary frequency following administration of URG101 compared to placebo.

Key facts

Study ID

NCT00517868

Run by

Urigen

People needed

28

Starts

2007-08-28

Expected to finish

2008-02-28

Last updated by the study team

2024-08-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male and female subjects >= 18 years of age
• moderate to severe symptoms of PBS/IC
• minimum pain/urgency/frequency scores
• female subjects on hormone therapy must be on stable dose for >= 3 months

You may not qualify if…

• positive pregnancy test or pregnant or lactating
• narcotics or medical marijuana within 3 months
• use of any investigational drug or device within 30 days
• bacterial cystitis within 30 days

Where it is running

• Citrus Valley Medical Research — Glendora, California, United States
• SD Uro-Research — San Diego, California, United States
• University of California, San Diego — San Diego, California, United States
• Scripps Clinic Medical Group — San Diego, California, United States
• Georgia Urology — Cartersville, Georgia, United States
• Urology San Antonio Research, P.A. — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.